Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 45.95 is 67% below its 2-year average of 139.05, near the low end of its 2-year range (0.00–1110.65).
As of the fiscal period ended Tuesday, June 30, 2026. 17.25% below its 12-month average of 55.53.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 45.95.
QUICK RATIO (ACID-TEST)
45.95
QUICK RATIO (ACID-TEST) AVG TTM
55.53
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-17.25%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+1271.68%
vs the sector median at left
Curanex Pharmaceuticals Inc Common Stock
Market Cap
$7.07M
Quick Ratio (Acid-Test)
45.95
TTM Avg
55.53
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.12M
Quick Ratio (Acid-Test)
0.95
TTM Avg
9.81
3Y Avg
5.30
5Y Avg
4.51
Market Cap
$7.15M
Quick Ratio (Acid-Test)
2.63
TTM Avg
4.46
3Y Avg
3.65
5Y Avg
4.69
Market Cap
$7.19M
Quick Ratio (Acid-Test)
1.52
TTM Avg
3.93
3Y Avg
10.24
5Y Avg
10.80
Market Cap
$7.19M
Quick Ratio (Acid-Test)
0.31
TTM Avg
1.26
3Y Avg
1.91
5Y Avg
5.52
Market Cap
$7.31M
Quick Ratio (Acid-Test)
1.37
TTM Avg
3.92
3Y Avg
4.12
5Y Avg
3.73
Market Cap
$6.74M
Quick Ratio (Acid-Test)
2.61
TTM Avg
3.40
3Y Avg
4.86
5Y Avg
5.09
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Curanex Pharmaceuticals Inc Common Stock (CURX) | $7.07M | 45.95 | 55.53 | N/A | N/A |
| KALA BIO, Inc. (KALA)vs › | $7.04M | 6.88 | 3.46 | 4.15 | 4.53 |
| Skye Bioscience, Inc. (SKYE)vs › | $7.12M | 0.95 | 9.81 | 5.30 | 4.51 |
| Longeveron Inc. (LGVN)vs › | $7.15M | 2.63 | 4.46 | 3.65 | 4.69 |
| Co-Diagnostics, Inc. (CODX)vs › | $7.19M | 1.52 | 3.93 | 10.24 | 10.80 |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.19M | 0.31 | 1.26 | 1.91 | 5.52 |
| Exicure, Inc. (XCUR)vs › | $6.88M | 0.56 | 2.82 | 3.15 | 3.36 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | 1.37 | 3.92 | 4.12 | 3.73 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.74M | 2.61 | 3.40 | 4.86 | 5.09 |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.46M | 14.52 | 3.29 | 11.30 | 10.20 |
Quick Ratio
45.95
Excludes inventory
Current Ratio
45.95
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 45.95 |
| 2026-03-31 | 62.87 |
| 2025-12-31 | 81.93 |
| 2025-09-30 | 77.53 |
| 2025-06-30 | 9.37 |
| 2025-03-31 | 3.61 |
| 2024-12-31 | 35.54 |
| 2024-09-30 | 102.04 |
| 2024-06-30 | 1110.65 |
| 2024-03-31 | 0.00 |
| 2023-12-31 | 0.00 |
